Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
91 Clinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt Department of Pediatric Oncology Prof. Douaa Mohamed Sayed Hussein 2022
92 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2022
93 Efficacy of Ketamine versus Magnesium Sulphate as Adjuvants to Levobupivacaine in Ultrasound Bilevel Erector Spinae Block in Breast Cancer Surgery (a Double-Blinded Randomized … Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2022
94 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
95 Efficacy of Ketamine versus Magnesium Sulphate as Adjuvants to Levobupivacaine in Ultrasound Bilevel Erector Spinae Block in Breast Cancer Surgery (a Double-Blinded Randomized … Department of Anesthesia, Intensive care and Pain management Prof. Khaled Mohamed Fares Ali 2022
96 Investigating causes and risk factors of pre-chemotherapy viremia in acute lymphoblastic leukemia pediatric patients Department of Cancer Biology Lamiaa Fadel Mohammed Abdelraheem 2022
97 Fine‑needle aspiration cytology versus core needle lymph node biopsy in axillary staging of breast cancer Department of Radiology Dr. Omar Mustafa Mahmoud Mohamed 2022
98 Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2022
99 Differential regulation of CD45 expression on granulocytes, lymphocytes, and monocytes in COVID-19 Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2022
100 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022